ImmuCell Corporation Amortization of Debt Issuance Costs
ImmuCell Corporation (ICCC) reported Amortization of Debt Issuance Costs of $21.61 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2025-08-14
- ImmuCell Corporation amortization of debt issuance costs for the quarter ending 2025-06-30 was $10.81K, a 0.01% decline year-over-year.
- ImmuCell Corporation amortization of debt issuance costs for the quarter ending 2025-03-31 was $10.81K, a 5.46% increase year-over-year.
- ImmuCell Corporation amortization of debt issuance costs for the quarter ending 2024-12-31 was $10.81K, a 7.06% increase year-over-year.
- ImmuCell Corporation amortization of debt issuance costs for the quarter ending 2024-09-30 was $10.80K, a 24.38% increase year-over-year.
- ImmuCell Corporation amortization of debt issuance costs for fiscal 2024 was $42.67K, a 88.63% increase from fiscal 2023.
- ImmuCell Corporation amortization of debt issuance costs for fiscal 2023 was $22.62K, a 195.36% increase from fiscal 2022.
- ImmuCell Corporation amortization of debt issuance costs for fiscal 2022 was $7.66K, a 2.33% decline from fiscal 2021.
- ImmuCell Corporation amortization of debt issuance costs for fiscal 2021 was $7.84K, a 1.27% decline from fiscal 2020.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 3 month as first filed | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 6 month as first filed | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 9 month as first filed | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | $10.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $21.61K 10-Q · filed 2025-08-14 | $32.42K derived: sum of 3 quarters · filed 2025-08-14 | $43.22K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2025-03-31 | $10.81K 10-Q · filed 2025-05-14 | $21.61K derived: sum of 2 quarters · filed 2025-05-14 | $32.42K derived: sum of 3 quarters · filed 2025-05-14 | $43.23K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-12-31 | $10.81K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $21.61K derived: sum of 2 quarters · filed 2025-03-28 | $32.42K derived: sum of 3 quarters · filed 2025-08-14 | $42.67K 10-K · filed 2025-03-28 | ||||
| 2024-09-30 | $10.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $21.61K derived: sum of 2 quarters · filed 2025-08-14 | $31.86K 10-Q · filed 2024-11-13 | $41.95K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-06-30 | $10.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $21.05K 10-Q · filed 2025-08-14 | $10.61K 10-Q · filed 2024-08-13 | $31.15K derived: sum of 3 quarters · filed 2025-08-14 | $39.84K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $10.25K 10-Q · filed 2025-05-14 | $5.02K 10-Q · filed 2024-05-14 | $20.34K derived: sum of 2 quarters · filed 2025-05-14 | $29.03K derived: sum of 3 quarters · filed 2025-05-14 | $30.95K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $10.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $18.78K derived: sum of 2 quarters · filed 2025-03-28 | $20.70K derived: sum of 3 quarters · filed 2025-03-28 | $22.62K 10-K · filed 2025-03-28 | $13.07K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $8.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $10.61K derived: sum of 2 quarters · filed 2024-11-13 | $12.53K 10-Q · filed 2024-11-13 | $8.20K 10-Q · filed 2023-11-13 | $14.44K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $1.92K 10-Q · filed 2023-08-10 | $3.84K 10-Q · filed 2024-08-13 | $5.76K derived: sum of 3 quarters · filed 2024-05-14 | $7.68K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2023-03-31 | $1.92K 10-Q · filed 2024-05-14 | $3.84K derived: sum of 2 quarters · filed 2024-05-14 | $5.76K derived: sum of 3 quarters · filed 2024-05-14 | $7.67K derived: sum of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | $1.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.84K derived: sum of 2 quarters · filed 2024-04-01 | $5.75K derived: sum of 3 quarters · filed 2024-04-01 | $7.66K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $1.92K 10-Q · filed 2022-11-21 | $3.83K derived: sum of 2 quarters · filed 2023-08-10 | $5.74K 10-Q · filed 2023-11-13 | $7.70K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-06-30 | $1.92K 10-Q · filed 2023-08-10 | $3.82K 10-Q · filed 2023-08-10 | $5.78K derived: sum of 3 quarters · filed 2023-08-10 | $7.74K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $1.91K 10-Q · filed 2023-05-11 | $3.87K derived: sum of 2 quarters · filed 2023-05-11 | $5.83K derived: sum of 3 quarters · filed 2023-05-11 | $7.79K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $1.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $3.92K derived: sum of 2 quarters · filed 2023-03-29 | $5.88K derived: sum of 3 quarters · filed 2023-03-29 | $7.84K 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | $1.96K 10-Q · filed 2022-11-21 | $3.92K derived: sum of 2 quarters · filed 2022-11-21 | $5.88K 10-Q · filed 2022-11-21 | $7.53K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2021-06-30 | $1.96K 10-Q/A · filed 2022-11-21 | $3.92K 10-Q/A · filed 2022-11-21 | $5.57K derived: sum of 3 quarters · filed 2022-11-21 | $7.13K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2021-03-31 | $1.96K 10-Q/A · filed 2022-11-21 | $3.61K derived: sum of 2 quarters · filed 2022-11-21 | $5.17K derived: sum of 3 quarters · filed 2022-11-21 | $6.74K derived: sum of 4 quarters · filed 2022-11-21 | ||||
| 2020-12-31 | $1.65K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.21K derived: sum of 2 quarters · filed 2022-03-30 | $4.78K derived: sum of 3 quarters · filed 2022-03-30 | $7.94K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | $1.56K 10-Q · filed 2021-11-15 | $3.13K derived: sum of 2 quarters · filed 2021-11-15 | $6.29K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | $1.56K 10-Q · filed 2021-08-12 | $4.73K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $3.17K 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $16.98K 10-K · filed 2021-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |